Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. GMRE
  6. >
  7. Earnings
stocks logo

GMRE Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of Global Medical REIT Inc(GMRE) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Global Medical REIT Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2025Q32025-11-04After Hours1.051.12+6.6738.15M37.23M-2.42+5.47+7.93
FY2025Q22025-08-05After Hours0.200.23+15.0035.57M37.97M+6.74-3.70-4.15
FY2025Q12025-05-07After Hours0.200.22+10.0035.49M34.62M-2.44-9.75-11.70
FY2024Q42025-02-27After Hours0.200.22+10.0034.87M35.16M+0.83+3.77+3.77
FY2024Q22024-08-06-0.200.22+10.0034.25M34.24M-0.03+1.98-2.09
FY2024Q12024-05-07-0.220.23+4.5534.68M35.12M+1.25-0.12+2.12
FY2023Q42024-02-27-0.220.23+4.5535.75M32.96M-7.80+0.97-1.72
FY2023Q32023-11-06-0.210.23+9.5235.98M35.51M-1.32-1.29-0.75
-2022-11-02-0.240.25+4.17----3.96-0.99
-2022-08-03-0.240.25+4.17----0.84-0.76
Financial AI Agent
Financial AI Agent

GMRE Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Global Medical REIT Inc reported performance for FY2025Q3, announced on 2025-11-04. The company achieved an EPS of 1.12, compared to analyst estimates of 1.05 by 6.67% . Revenue for the quarter reached 37.23M compared to expectations of 38.15M by -2.42% .
The stock price reacted with a 5.47% one-day change and a 7.93% five-day change following the earnings release. These movements reflect market reaction in Global Medical REIT Inc growth trajectory and strategic initiatives.

GMRE Earnings Forecast

Looking ahead, Global Medical REIT Inc(GMRE) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 37.77M and an EPS of 0.19.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.23%, while EPS estimates have been Revise Downward by -204%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -2.09% . These revisions correlate with a -13.97% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Global Medical REIT Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between GMRE's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-204%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Downward
down Image
-2.09%
In Past 3 Month
Stock Price
Go Down
down Image
-13.97%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:147.14M
--
EPS Estimate-Annual FY 2025:-0.26
—
Stock Price32.69
Intellectia AI SwingMax
Intellectia AI SwingMax

GMRE Revenue and EPS Performance: A Historical Perspective

Global Medical REIT Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-04,After Hours):
EPS: 1.12 (Actual) vs.1.05 (Estimate) (6.67%)
Revenue: 37.23M (Actual) vs. 38.15M (Estimate) (-2.42%)
Price Reaction: 5.47%(1-Day), 7.93%(5-Day)
FY2025Q2 (2025-08-05,After Hours):
EPS: 0.23 (Actual) vs.0.20 (Estimate) (15.00%)
Revenue: 37.97M (Actual) vs. 35.57M (Estimate) (6.74%)
Price Reaction: -3.70%(1-Day), -4.15%(5-Day)
FY2025Q1 (2025-05-07,After Hours):
EPS: 0.22 (Actual) vs.0.20 (Estimate) (10.00%)
Revenue: 34.62M (Actual) vs. 35.49M (Estimate) (-2.44%)
Price Reaction: -9.75%(1-Day), -11.70%(5-Day)
Earnings Reaction
The chart below shows how GMRE performed 10 days before and after its earnings report, based on data from the past quarters. Typically, GMRE sees a -1.35% change in stock price 10 days leading up to the earnings, and a +1.26% change 10 days following the report. On the earnings day itself, the stock moves by -0.39%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 5.47% on the day following the earnings release and then changed by 7.43% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
AI Stock Picker
AI Stock Picker

Transcript Summary

Global Medical REIT Inc (GMRE) Q3 2025 Earnings Call Summary
Positive
2025-11-05
The earnings call highlights strong occupancy projections and strategic asset management, with plans to redeploy capital at positive spreads. Despite a dividend reduction, the focus on growth initiatives and asset recycling is promising. The Q&A reveals management's proactive approach to leverage and asset sales, with potential for significant acquisitions. While some management responses lacked specificity, the overall sentiment is positive due to strong operational metrics and strategic planning.
Global Medical REIT Inc (GMRE) Q2 2025 Earnings Call Summary
Neutral
2025-08-06
The earnings call presented mixed signals: a dividend reduction and occupancy decline are concerning, but strategic asset recycling and growth initiatives offer potential upside. The Q&A revealed uncertainties in refinancing and asset disposition, while management's lack of clarity on certain issues adds risk. Overall, the balance of positive and negative factors suggests a neutral stock price movement.
Global Medical REIT Inc (GMRE) Q1 2025 Earnings Call Summary
Negative
2025-05-08
The earnings call reflects mixed financial performance with a slight decline in revenues and AFFO, and a lower lease renewal rate, indicating potential occupancy risks. The lack of share repurchase or dividend program, coupled with management's unclear responses in the Q&A, further dampens sentiment. Despite optimistic market outlooks and strategic acquisitions, the inability to provide clear guidance on key issues, such as the East Orange facility and dividend sustainability, suggests a negative short-term stock reaction.
Global Medical REIT Inc (GMRE) Q1 2025 Earnings Call Summary
Neutral
2025-05-08
The earnings call revealed mixed results: a decrease in total revenues and AFFO, but stable net income and occupancy. The Q&A highlighted management's unclear responses on key issues like rent collection and dividend sustainability. The reaffirmed AFFO guidance and stable leverage ratio are positive, but lower retention and uncertain strategic direction weigh negatively. Without a market cap, the prediction is neutral, expecting a -2% to 2% range.
Global Medical REIT Inc (GMRE) Q4 2024 Earnings Call Summary
Neutral
2025-03-01
The earnings call presented mixed signals: a 6.7% revenue increase is positive, but the lack of a shareholder return plan and CEO succession costs are negative. The Q&A highlighted management's avoidance of direct answers, adding uncertainty. Despite the revenue growth, the financial metrics showed declines in FFO and AFFO, and the lack of guidance adjustments is concerning. Without a market cap, the reaction is uncertain, but overall, the sentiment remains neutral due to balanced positive and negative factors.
Global Medical REIT Inc (GMRE) Q4 2024 Earnings Call Summary
Negative
2025-02-28
The earnings call reveals several concerns: CEO succession costs, tenant bankruptcy risks, and increased expenses impacting financials. Despite a net income improvement, FFO and AFFO decreased, and no shareholder return plans were announced. Market uncertainties, such as debt and acquisition completion risks, further contribute to a negative sentiment. The Q&A revealed management's vague responses, especially on strategic reviews and CEO criteria, raising doubts. Overall, the negative aspects outweigh the positives, leading to a stock price prediction of -2% to -8% over the next two weeks.
Global Medical REIT, Inc. (GMRE) Q3 2024 Earnings Call Summary
Positive
2024-11-07
The earnings call summary reflects strong financial performance with a 10% revenue increase and 15% net income growth. The company maintains stable margins and is committed to shareholder returns with a dividend increase. While there are risks noted, the strategic initiatives, including acquisitions and product launches, suggest optimism. The Q&A indicates management is proactive in addressing supply chain challenges. Overall, despite some uncertainties, the positive financial outlook and strategic growth plans support a positive sentiment rating.
Global Medical REIT, Inc. (GMRE) Q2 2024 Earnings Call Summary
Neutral
2024-08-07
The earnings call presents mixed signals: a net loss and revenue decline are negative, yet reduced expenses and stable occupancy are positive. The Q&A reveals cautious optimism about future investments and interest rates, but uncertainty around the Steward Health Care bankruptcy and lack of shareholder return plans temper the outlook. The lack of new partnerships or guidance changes keeps the sentiment neutral, and without the market cap, the stock reaction is unpredictable.

People Also Watch

FAQ

arrow icon

What were the key highlights of GMRE’s latest earnings report for FY2025Q3?

GMRE reported its FY2025Q3 earnings on 2025-11-04, showcasing a revenue of 37.23M against an estimate of 38.15M, resulting in a -2.42% surprise. The EPS was 1.12, surpassing the expected 1.05 by 6.67% . The stock experienced a 5.47% price change on the earnings day and a 7.93% change over the next five days, reflecting market reactions to the results.
arrow icon

How did GMRE’s stock price react after the FY2025Q3 earnings release?

Following GMRE’s FY2025Q3 earnings announcement on 2025-11-04, the stock price moved by 5.47% on the day of the release. Over the subsequent five days, it saw a 7.93% change. Historically, GMRE’s stock price tends to shift by an average of -1.35% in the 10 days leading up to earnings and +1.26% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for GMRE for 2025/Q4?

For 2025/Q4, analysts estimate GMRE’s annual revenue to reach 37.77M, while the EPS is projected at 0.19. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.23% and EPS estimates Revise Downward by -2.09% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does GMRE’s stock price correlate with earnings forecast revisions?

The correlation between GMRE’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.23%, while EPS estimates moved Revise Downward by -2.09% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from GMRE’s next earnings report?

Based on historical trends, GMRE’s stock price typically moves by -1.35% in the 10 days before its earnings and +1.26% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.19 and revenue of 37.77M.
arrow icon

What is the sentiment in Global Medical REIT Inc (GMRE) Q3 2025 Earnings Call Summary?

The earnings call highlights strong occupancy projections and strategic asset management, with plans to redeploy capital at positive spreads. Despite a dividend reduction, the focus on growth initiatives and asset recycling is promising. The Q&A reveals management's proactive approach to leverage and asset sales, with potential for significant acquisitions. While some management responses lacked specificity, the overall sentiment is positive due to strong operational metrics and strategic planning.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free